Long-Term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of alzheimer's disease

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Essa, Musthafa Mohamed ^a,b   Subash, Selvaraju ^a   Akbar, Mohammed ^c   Al Adawi, Samir ^a   Guillemin, Gilles J ^b  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b MACQUARIE UNIVERSITY   (Australia)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; EOTAXIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DATE (FRUIT); DIET SUPPLEMENTATION; FEMALE; FIG; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; POMEGRANATE; PROTEIN BLOOD LEVEL; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; BLOOD; BRAIN; CHEMISTRY; DIETARY SUPPLEMENT; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FICUS; FRUIT; LYTHRACEAE; METABOLISM; PATHOLOGY; PHOENIX (PLANT);

LYTHRACEAE; MUS; MUS MUSCULUS;

ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CYTOKINES; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FICUS; FRUIT; MICE; MICE, TRANSGENIC; PHOENICEAE; PUNICACEAE;

EID: 84926356453     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120964     Document Type: Article

References (112)

1. Coyle JT, Price DL, Delong MR. Alzheimer's disease: a disorder of central cholinergic innervation. Science. 1983; 219:1184-1190. PMID: 6338589
2. Zlokovic BV. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 2005; 28, 202-208. PMID: 15808355
3. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron. 2010; 68:409-427. doi: 10.1016/j.neuron.2010.09.043 PMID: 21040844
4. Marchesi VT. Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J. 2011; 25:5-13. doi: 10.1096/fj.11-0102ufm PMID: 21205781
5. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 2011; 12:723-738. doi: 10.1038/nrn3114 PMID: 22048062
6. Strauss S J. Bauer J, Ganter U, Jonas M, Berger B Volk BB. Detection of interleukin-6 and 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients, Lab. Invest. 1992; 66:223-230. PMID: 1370967
7. Griffin WST, Sheng JG Roberts GW, Mark RE. Interleukin-1 expression in different plaque types in Alzheimer's disease: signifcance in plaque evolution, J. Neuropathol. Exp. Neurol. 1995; 54:276-281. PMID: 7876895
8. Patterson PH. (1995). Cytokines in Alzheimer's disease and multiple sclerosis, Curr. Opin. Neurobiol. 1995; 5:642-646. PMID: 8580716
9. Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, Besedovsky HO. A neuromodulatory role of interleukin-1b in the hippocampus, Physiology. 1998; 95:7778-7783. PMID: 9636227
10. Murray CA, Lynch MA. Evidence that increased hippocampal expression of the cytokine interleukin-1b is a common trigger for age- and stress-induced impairments in long-term potentiation, J. Neurosci. 1998; 18: 2974-2981. PMID: 9526014
11. Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain, Proc. Natl. Acad. Sci. USA 1997; 94:1500-1505. PMID: 9037082
12. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann. Neurol. 2002; 52:168-174. PMID: 12210786
13. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 2003; 61:76-80. PMID: 12847160
14. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, et al. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch. Neurol. 2004; 61:668-672. PMID: 15148142
15. Dik MG, Jonker C, Hack C.E, Smit JH, Comijs HC, Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology. 2005; 64:1371-1377. PMID: 15851726
16. Rainero I, Bo M, Ferrero M, Valfre W, Vaula G, Pinessi L. Association between the interleukin-1alpha gene and Alzheimer' s disease: a meta-analysis. Neurobiol. Aging. 2004; 25:1293-1298. PMID: 15465625
17. McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 1996; 47:425-432. PMID: 8757015
18. in t'Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, et al. Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 2001; 345:1515-1521. PMID: 11794217
19. van Gool WA, Aisen PS, Eikelenboom P. Anti-inflammatory therapy in Alzheimer's disease: is hope still alive? J. Neurol. 2003; 250:788-792. PMID: 12883918
20. Muthaiyah B, Essa MM, Chauhan V, Chauhan A. Protective effects of walnut extract against amyloid beta peptide-induced cell death and oxidative stress in PC12 cells. Neurochem Res. 2011; 36(11):2096-103. doi: 10.1007/s11064-011-0533-z PMID: 21706234
21. Essa MM, Guillemin GJ, Al-Adawi S, Al-Asmi A, Vaishnav R, Ramachandiran N, et al. Anti amyloidogenic effect of dates with reference to their protection against Alzheimer's disease. The Dates-Genous Phoneix" Eds: Manickavasagan A, Essa MM, Sukumar E, CRC press, UK. 2010a;397-403.
22. Essa MM, Vijayan RK, Castellano-Gonzalez G, Memon MA, Braidy N, Guillemin GJ. Neuroprotective Effect of Natural Products against Alzheimer's Disease. Neurochem Res. 2010b; 37(9):1829-42.
23. Jabir R, Hasnaoui N, Mars M, Marrakchi M, Trifi M. Characterization of Tunisian pomegranate (Punica granatum L.) cultivars using amplified fragment length polymorphism analysis. Sci Hortic. 2008; 115:231-237.
24. Melgarejo P, Martínez JJ, Hernández Fca, Martínez R, Legua P, Oncina R, et al. Cultivar identification using 18S-18S rDNA intergenic spacer-RFLP in pomegranate (Punica granatum L.). Sci. Hortic. 2009; 120:500-503.
25. Kelawala NS, Ananthanarayan L. Antioxidant activity of selected foodstuffs. Int J Food Sci Nutr. 2004; 55:511-516. PMID: 15762315
26. Xu J, Guo CJ, Yang JJ, Wei JY, Li YF, Pang W, et al. Intervention of antioxidant system function of aged rats by giving fruit juices with different antioxidant capacities. Zhonghua Yu Fang Yi Xue Za Zhi. 2005; 39:80-83. PMID: 15842822
27. González-Molina E, Moreno DA, García-Viguera C. A new drink rich in healthy bioactives combining lemon and pomegranate juices. Food Chemistry. 2009; 115:1364-1372.
28. Loren DJ, Seeram NP, Schulman RN, Holtzman DM. Maternal Dietary Supplementation with Pomegranate Juice Is Neuroprotective in an Animal Model of Neonatal Hypoxic-Ischemic Brain Injury. Pediatr Res 2005; 57(6):858-64. PMID: 15774834
29. Kislev ME, Hartmann A, Bar-Yosef O. Early domesticated fig in the Jordan Valley", Science, 2006a 312:1372-1374 PMID: 16741119
30. Kislev ME, Hartmann A, Bar-Yosef O. Response to Comment on "Early Domesticated Fig in the Jordan Valley" Science, 2006b; 314:1683. PMID: 17170278
31. Aljane F, Ferchichi A. Assessment of Genetic Diversity among Some Southern Tunisian Fig (Ficus carica L.) Cultivars Based on Morphological Descriptors. Jordan Journal of Agricultural Sciences. 2009; 5(1): 1-16.
32. Lianju W, Weibin J, Kai M, Zhifeng L Yelin W. The production and research of fig (Ficus carica L.) in China. Acta Horticulturae 2003; 605, pp. 191-196.
33. Vinson JA, Zubik L, Bose P, Samman N. Dried fruits: excellent in vitro and in vivo antioxidants. J Am Coll Nutr 2005; 24, pp. 44-50.
34. Solomon A, Golubowicz S, Z. Yablowicz Z, Grossman S, Bergman M, Gottlieb HE, et al. "Antioxidant activities and anthocyanin content of fresh fruits of common fig (Ficus carica L.)," Journal of Agricultural and Food Chemistry 2006; 54, 20, pp. 7717-7723. PMID: 17002444
35. Veberic R, Colaric M, Stampar F. Phenolic acids and flavonoids of fig fruit (Ficus carica L.) in the northern Mediterranean region. Food Chemistry 2008; 106, 1, pp. 153-157.
36. Vinson JA. The functional properties of figs. Cereal Foods World, 1999; 44:82-87.
37. Kritikar KD, Basu BD. In: Blatter E., Caius I.F. (Eds.), Indian Medicinal Plants. second ed. International Book Distributors, Dehradun, 1986;2329-2331.
38. 2 scavenging and prevention of glutathione depletion in fibroblast cells by cyanidin-3- rhamnoglucoside isolated from fig (Ficus carica L.) fruits. J. Agric. Food Chem. 2010a; 58:7158-7165. doi: 10.1021/jf100153z PMID: 20443568
39. Solomon A, Golubowicz S, Yablowicz Z, Bergman M, Grossman S, Altman A, et al. Protection of fibroblasts (NIH-3T3) against oxidative damage by cyanidin-3-rhamnoglucoside isolated from fig fruits (Ficus carica L.). J. Agric. Food Chem, 2010b; 58: 6660-6665. doi: 10.1021/jf100122a PMID: 20443626
40. Gilani AH, Mehmood MH, Janbaz KH, Khan A, Saeed SA. Ethnopharmacological studies on antispasmodic and antiplatelet activities of Ficus carica. J. of Ethnopharmacology 2008; 119:1-5.
41. Patil VV, Bhangale SC, Patil VR. Evaluation of anti-pyretic potential of Ficus carica leaves. Int. J. of Pharm. Sci. Rev & Res. 2010; 2. PMID: 15458825
42. Aref HL, Salah KBH, Chaumont JP, Fekih A, Aouni M, Said K. In vitro Antimicrobial activity of four Ficus carica latex fractions against resistant human pathogens (antimicrobial activity of Ficus carica latex). Pak J Pharm Sci. 2010; 23(1):53-58. PMID: 20067867
43. Mohamad S, Zin NM, Wahab HA, Ibrahim P, Sulaiman SF, Zahariluddin AS, et al. Antituberculosis potential of some ethnobotanically selected Malaysian plants. J Ethnopharmacol.2010; 133(3):1021-1026. doi: 10.1016/j.jep.2010.11.037 PMID: 21094237
44. Patil VV, Bhangale SC, Patil VR. Evaluation of antipyretic potential of Ficus carica leaves. International Journal of Pharmaceutical Sciences Review and Research. 2010; 2(2):48-50.
45. Wang G, Wang H, Song Y, Jia C, Wang Z, Xu H. Studies on anti-HSV effect of Ficus carica leaves. Journal of Chinese medicinal materials. 2004; 27:754-756. PMID: 15850358
46. Richter G, Schwarz HP, Dorner F, Peter L. Activation and inactivation of human factor X by proteases derived from Ficus carica. British Journal of Haematology.2002; 119:1042-1051. PMID: 12472586
47. Canal JR, Torres MD, Romero A, Perez CA. Chloroform extract obtained from a decoction of Ficus carica leaves improves the cholesterolaemic status of rats with streptozotocin-induced diabetes. Acta Physiologica Hungarica. 2000; 87:71-76. PMID: 11032050
48. Rubnov S, Kashman Y, Rabinowitz R, Schlesinger M, Mechoulam R. Suppressors of cancer cell proliferation from fig (Ficus carica) resin: isolation and structure elucidation. J Nat Prod. 2001; 64(7):993-996. PMID: 11473446
49. Yancheva SD, Golubowicz S, Yablowicz Z, Perl A, Flaishman MA. Efficient agrobacterium-mediated transformation and recovery of transgenic fig (Ficus carica L.) plants. Plant Science.2005; 168(6):1433-1441.
50. Gond NY, Khadabadi SS. Hepatoprotective activity of Ficus carica leaf extract on rifampicin-induced hepatic damage in rats. Indian J Pharm Sci.2008; 70(3):364-366. doi: 10.4103/0250-474X.43003 PMID: 20046747
51. Khadabadi SS, Gond NY, Ghiware NB, Shendarkar GR. Hepatoprotective effect of Ficus carica leaf in chronic hepatitis. Indian Drugs.2007; 44(1):54-57. PMID: 17277439
52. Perez C, Canal JR, Campillo JE, Romero A, Torres MD. Hypotriglyceridaemic activity of Ficus carica leaves in experimental hypertriglyceridaemic rats. Phytotherapy Research.1999; 13:188-191. PMID: 10353154
53. KrishnaMohan G, Pallavi E, RaviKumar B, Ramesh M, Venkatesh S. "Hepatoprotective activity of Ficus carica Linn leaf extract against carbon tetrachloride-induced hepatotoxicity in rats", DARU, 2007; 15: 3:162-166.
54. Vinson JA, Hao Y, Zubik L. Phenol antioxidant quantity and quality in foods: Vegetables. Journal of Agricultural and Food Chemistry. 1998; 46:3630-3634.
55. Puri A, Sahai R, Singh KL, Saxena RP, Tandon JS, Saxena KC. Immunostimulant activity of dry fruits and plant materials used in Indian traditional medical system for mothers after child birth and invalids. Journal of Ethnopharmacology. 2000; 71: 89-92. PMID: 10904150
56. Al-Maiman SA. Effect of date palm (Phoenix dactylifera) seed fibers on plasma lipids in rats", Journal of King Saud University.2005; 17:117-123.
57. El-Mougy SA, Abdel-Aziz SA, Al-Shanawany M, Omar A. The gonadotropic activity of Palmae in mature male rats. Alexandria Journal of Pharmaceutical Sciences. 1991; 5:156-159.
58. Saafi EB, Louedi M, Elfeki A, Zakhama A, Najjar MF, Hammami M, et al. Protective effect of date palm fruit extract (Phoenix dactylifera L.) on dimethoate induced-oxidative stress in rat liver. Exp Toxicol Pathol.2011; 63(5):433-441. doi: 10.1016/j.etp.2010.03.002 PMID: 20359872
59. Al Qarawi AA, Abdel-Rahman H, Mousa HM, Ali BH, El-Mougy SA. Nephroprotective Action of Phoenix dactylifera in gentamicin-induced nephrotoxicity. Pharmaceutical Biology.2008; 46:227-230.
60. Ishurda O, John FK. The anti-cancer activity of polysaccharide prepared from Libyan dates (Phoenix dactylifera L.). Carbohydrate Polymers.2005; 59:531-535.
61. Sallal AK, Ashkenani A. Effect of date extract on growth and spore germination of Bacillus subtilis. Microbios. 1989; 59:203-210. PMID: 2512469
62. Shraideh ZA, Abu-El-Teen KH, Sallal AKJ. Ultrastructural effects of date extract on Candida albicans. Mycopathologia.1998; 142:119-123. PMID: 10052161
63. Vayalil PK. Antioxidant and antimutagenic properties of aqueous extract of date fruit (Phoenix dactylifera L. arecaceae). Journal of Agricultural and Food Chemistry. 2002; 50:610-617. PMID: 11804538
64. Gamil-Abdel-Hafez M, Fouad-Shalaby A, Akhal I. Chemical composition of 15 varieties of dates grown in Saudi Arabia. Fourth Symposium on biological aspects of Saudi Arabia.1980;89-91.
65. Mansouri A, Embarek G, Kokkalou E, Kefalas P. Phenolic profile and antioxidant activity of the Algerian ripe date palm fruit (Phoenix dactylifera). Food Chemistry.2005; 89:411-420.
66. Al-Farsi M, Alasalvar C, Morris A, Baron M, Shahidi F. Compositional and sensory characteristics of three native sun-dried date (Phoenix dactylifera L.) varieties grown in Oman. Journal of Agricultural and Food Chemistry. 2005; 53:7586-7591. PMID: 16159190
67. Biglari F, AlKarkhi Abbas FM, Easa AM. Antioxidant activity and phenolic content of various date palm (Phoenix dactylifera) Fruits from Iran. Food Chemistry.2008; 107:1636-1641.
68. Allaith AAA. Antioxidant activity of Bahraini date palm (Phoenix dactylifera L.) fruit of various cultivars. International Journal of Food Science & Technology. 43(6):1033-1040.
69. Vinson JA, Zubik L, Bose P, Samman N, Proch J. Dried fruits: Excellent in vitro and in vivo antioxidants. Journal of the American College of Nutrition. 2005; 24:44-50. PMID: 15670984
70. Al-Farsi M, Morris A, Baron M. Functional properties of Omani dates (Phoenix dactylifera). The Third International Date Palm Conference. Abu Dhabi, United Arab Emirates.2006;19-21.
71. Subash M, Essa MM, Al-Asmi A, Al-Adawi S, Vaishnav R, Guillemin GJ. Effect of dietary supplementation of dates in Alzheimer's disease APPsw/2576 transgenic mice on oxidative stress and antioxidant status. Nutritional neuroscience. 2014.
72. Subash S, Essa MM, Braidy N, Al-Jabri A, Vaishnav R, Al-Adawi S, et al. Consumption of fig fruits grown in Oman can improve memory, anxiety, and learning skills in a transgenic mice model of Alzheimer's disease. Nutritional neuroscience. 2014.
73. Subash S, Essa MM, Al-Asmi A, Al-Adawi S, Vaishnav R. Chronic Dietary Supplementation of 4% Figs on the Modification of Oxidative Stress in Alzheimer's Disease Transgenic Mouse Model,"BioMed Research International; 2014, 8 pages.
74. Subash S, Essa MM, Al-Asmi A, Al-Adawi S, Vaishnav R, Braidy N, et al. Pomegranate from Oman Alleviates the Brain Oxidative Damage in Transgenic Mouse Model of Alzheimer's disease. Journal of Traditional and Complementary Medicine. 2014; 4(4):232. doi: 10.4103/2225-4110.139107 PMID: 25379464
75. Subash S, Essa MM, Guillemin G, Al-Adawi S, Al-Asmi A, Vaishnav A. Dietary supplementation of pomegranate reduces the brain oxidative stress in transgenic tg2576 mouse model of Alzheimer disease (1025.5) The FASEB Journal. 2013; 28: (1 Supplement), 1025.5.
76. Subash S, Essa MM, Al-Adawi S, Al-Asmi A, Vaishnav R, Guillemin GJ. Nine months of dietary supplementation of Omani fruits (pomegranate, figs and dates) improves the memory, anxiety and learning skills in Alzheimer's disease transgenic mice (845.1) The FASEB Journal. 2014; 28:(1 Supplement), 845.1.
77. Tota S, Awasthi H, Kamat PK, Nath C, Hanif K. Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav. BrainRes.2010; 209:73-79. doi: 10.1016/j.bbr.2010.01.017 PMID: 20096732
78. Varadarajan S, Yatin S, Aksenova M, Butterfield DA. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity, J. Struct. Biol. 2000; 130:184-208. PMID: 10940225
79. Butterfield DA, Castegna A, Lauderback CM, Drake J. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death, Neurobiol. Aging 2002; 23:655-664. PMID: 12392766
80. Cosentino SA, Stern Y, Sokolov E, Scarmeas N, Manly JJ, Tang MX, et al. Plasma {beta}-amyloid and cognitive decline. Arch Neurol.2010; 67:1485-90. doi: 10.1001/archneurol.2010.189 PMID: 20697031
81. Laske C, Sopova K, Gkotsis C, Eschweiler GW, Straten G, Gawaz M, et al. Amyloid-beta peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer's disease patients. J Alzheimer's Dis.2010; 21:1263-9.
82. Kuo YM, Kokjohn TA, Beach TG, Sue LI, Brune D, Lopez JC. Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains. J Biol Chem. 2001; 276:12991-8. PMID: 11152675
83. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci. 2001; 21:372-81. PMID: 11160418
84. Subash S, Essa MM, Al-Asmi A, Al-Adawi S, Vaishnav R, Guillemin GJ. Effect of dietary supplementation of dates in Alzheimer's disease APPsw/2576 transgenic mice on oxidative stress and antioxidant status. Nutritional Neuroscience.2014; (in press).
85. Dinarello CA. Biologic basis for interleukin-1 in disease, Blood. 1996; 87: 2095-2147. PMID: 8630372
86. Rothwell J, Hopkins SJ. Cytokines and the nervous system II: Actions and mechanisms of action, Trends Neurosci. 1995; 18: 130-136. PMID: 7754524
87. Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses, Endocr. Rev. 1996; 17: 64-102. PMID: 8641224
88. Haas HS, Schauenstein K. Neuroimmunomodulation via limbic structures. The neuroanatomy of psychoimmunology, Prog. Neuro biol. 1997; 51:195-222.
89. Fillit H, Ding WH, Buee L, Kalman J, Altstiel L, Lawlor B, et al. Elevated circulating TNF levels in Alzheimer's disease, Neurosci. Lett. 1991; 129:318-320. PMID: 1745413
90. Blum-Degen D, Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P. IL-1βand IL-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients, Neurosci. Lett. 1995; 202:17-20. PMID: 8787820
91. Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, et al. Clinical trail of indomethacin in Alzheimer's disease, Neurology. 1993; 43:1609-1611. PMID: 8351023
92. Breitner JCS, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ, et al. Inverse association of antiinflammatory treatments and Alzheimer's disease: initial results of a co-twin control study, Neurology. 1994; 44:; 227-232. PMID: 8309563
93. Griffin WST, Sheng JG, Roberts GW, Mark RE. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution, J. Neuropathol. Exp. Neurol. 1995; 54:276-281. PMID: 7876895
94. Huell M, Stauss S, Volk B, Berger M, Bauer J. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients, Acta Neuropathol. 1995; 89:544-551. PMID: 7676810
95. Fagarasan MO, Aisen PS. IL-1 and anti-inflammatory drugs modulate Ab cytotoxicity in PC12 cells, Brain Res. 1996; 723;231-234. PMID: 8813406
96. Meda L, Cassatella MA, Szendrei GI, Otvos LJ, Baron P, Villalba M, et al. Activation of microglial cells by b-amyloid protein and interferon-g, Nature. 1995; 374: 647-650. PMID: 7715705
97. Shukla M, Gupta K, Rasheed Z, Khan KA, Haqqi TM. Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis. Nutrition. 2008; 24:733-743. doi: 10.1016/j.nut.2008.03.013 PMID: 18490140
98. Neyrinck AM, Van-Hee VF, Bindels LB, De Backer F, Cani PD, Delzenne NM. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota. British Journal of Nutrition.2013; 109: 802-809. doi: 10.1017/S0007114512002206 PMID: 22676910
99. Celik F, Gocmez C, Bozkurt M, I. Kaplan I, Kamasak K, Akil E, et al. Neuroprotective effects of carvacrol and pomegranate againstmethotrexateinduced toxicity in rats. European Review for Medical and Pharmacological Sciences.2013; 17: 2988-2993. PMID: 24302176
100. de Oliveira de JFF, Garreto DV, da Silva MCP, Fortes TS, de Oliveira RB, Nascimento FRF, et al. Therapeutic potential of biodegradable microparticles containing Punica granatum L. (pomegranate) in murine model of asthma. Inflamm. Res.2013; 62:971-980. doi: 10.1007/s00011-013-0659-3 PMID: 23979691
101. Asgary S, Sahebkar A, Afshani MR, Keshvari M, Haghjooyjavanmard S, Rafieian-Kopaei M. Clinical Evaluation of Blood Pressure Lowering, Endothelial Function Improving, Hypolipidemic and Anti-Inflammatory Effects of Pomegranate Juice in Hypertensive Subjects. Phytother. Res. 2014; 28: 193-199. doi: 10.1002/ptr.4977 PMID: 23519910
102. Winand J, Schneider YJ. The anti-inflammatory effect of a pomegranate husk extract on inflamed adipocytes and macrophages cultivated independently, but not on the inflammatory vicious cycle between adipocytes and macrophages. Food Funct. 2014; 5: 310. doi: 10.1039/c3fo60443h PMID: 24336779
103. Tezcan F, Gultekin-Ozguven M, Diken T, Ozcelik B, Erim FB. Antioxidant activity and total phenolic, organic acid and sugar content in commercial pomegranate juices. Food Chemistry.2009; 115:873-7.
104. Zhang L, Fu Q, Zhang Y. Composition of anthocyanins in pomegranate flowers and their antioxidant activity. Food Chemistry 2011; 127:1444-49.
105. Jing P, Ye T, Shi H. Antioxidant properties and phytochemical composition of China-grown pomegranate seeds. Food Chemistry. 2012; 132:1457-1464.
106. Hartman RE, Shah A, Fagan AM, Schwetye KE, Parsadanian M, Schulman RN, et al. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis 2006; 24:506-15 PMID: 17010630
107. Braidy N, Subash S, Essa MM, Vaishnav R, Al-Adawi S, Al-Asmi A, Al-Senawi H, et al. Neuroprotective effects of a variety of Pomegranate Juice extracts (PJE) against MPTP-induced cytotoxicity and oxidative stress in human primary neurons. Oxid Med Cell Longev 2013;685909.
108. Rojanathammanee L, Puig KL, Combs CK. Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease.J Nutr 2013; 143(5):597-605. doi: 10.3945/jn.112.169516 PMID: 23468550
109. Funakoshi-Tago M, Nakamura K, Tago K, Mashino T, Kasahara T. Anti-inflammatory activity of structurally related flavonoids, Apigenin, Luteolin and Fisetin. Department of Biochemistry, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512.
110. Patel D, Shukla S, Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise. Department of Urology, Case Western Reserve University, Cleveland, OH 44106, USA.
111. Alturki SM, Shehata WF, Mohammed I. Aldaej MI. Influence of Nutrient Medium on Antioxidants Production of Date Palm (Phoenix dactylifera L.) Cultivars in vitro. Asian Journal of Plant Sciences. 2013; 12: 119-127.
112. Dillard CJ, German JB. Phytochemicals: nutraceuticals and human health. J. Sci. Food Agric. 2000; 80: 1744-1756.